P2.08 .22 In Field Progression Rates Following Concurrent Chemoradiotherapy for Stage III Non Small Cell Lung Cancer
Back to course
Asset Subtitle
Drew Moghanaki
Meta Tag
Speaker Drew Moghanaki
Topic Local-Regional Non-small Cell Lung Cancer
Powered By